ד"ר נעמי ורבלוף בקר

Articles in periodical

Weiser, M., Werbeloff, N., Vishna, T., Yoffe, R., Lubin, G., Shmushkevitch, M. & Davidson M. (2008) Elaboration of Immigration and risk for schizophrenia. Psychological Medicine, 38(8):1113-1119.

Weiser, M., Reichenberg, A., Werbeloff, N., Kravitz, E., Rabinowitz, J., Lubin, G., Shmushkevitch, M., Nahon, D., Addington, J., Noy, S. & Davidson, M. (2008). Poor family functioning increases risk for psychotic disorders in male adolescents with behavioral disturbances. Acta Psychiatrica Scandinavica, 117(3):225-231.

Weiser, M., Reichenberg, A., Werbeloff, N., Kleinhaus, K., Lubin, G., Shmushkevitch, M., Caspi, A., Malaspina, D. & Davidson, M. (2008). Advanced Parental Age at Birth Is Associated With Poorer Social Functioning in Adolescent Males: Shedding Light on a Core Symptom of Schizophrenia and Autism. Schizophrenia Bulletin, 34(6): 1042-1046.

Weiser, M., Lubin, G., Caspi, A., Rabinowitz, J., Shmushkevitz, M., Yoffe, R., Werbeloff, N., Halperin, D. & Davidson, M. (2008). Dysthymia in male adolescents is associated with increased risk of later hospitalization for psychotic disorders: a historical-prospective cohort study. Early Intervention in Psychiatry, 2(2): 67-72.

Weiser, M., Reichenberg, A., Werbeloff, N., Halperin, D., Kravitz, E., Yoffe, R. & Davidson, M. (2009). Increased number of offspring in first degree relatives of psychotic individuals: a partial explanation for the persistence of psychotic illnesses. Acta Psychiatrica Scandinavica, 119 (6): 466-471.

Davidson, M., Galderisi, s., Weiser, M., Werbeloff, N., Fleischhacker, W.W., Keefe, R.S., Boter, H., Keet, I.P.M., Dan Prelipceanu, D., Rybakowski, J.K., Libiger, J., Hummer, M., Dollfus, S., López-Ibor, J.J., Hranov, L.G., Gaebel, W., Peuskens, J., Lindefors, N., Riechler-Rössler, A. & Kahn. R.S. (2009). Cognitive effects OF Antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). American Journal of Psychiatry, 166(6): 675-682.

Gelkopf, M., Roffe, Z., Behrbalk, P., Melamed, Y., Werbeloff, N. & Bleich, A. (2009). Attitudes, opinions, behaviors and emotions of the nursing staff towards patient restraint. Issues in Mental Health Nursing, 30(12): 758-763.

Weiser, M., Zarka, S., Werbeloff, N., Kravitz, E. & Lubin, G. (2010). Cognitive test scores in male adolescent cigarette smokers compared to non-smokers: a population-based study. Addiction, 105 (2): 358-363.

Lubin, G., Werbeloff, N., Halperin D., Shmushkevitch, M., Weiser, M. & Knobler. H.Y. (2010). Decrease in suicide rates after a change of policy reducing access to firearms in adolescents. Suicide and Life Threatening Behavior, 40(5): 421-4.

Weiser, M., Werbeloff, N., Levine, A., Livni, G., Schreiber, S., Halperin, D., Yoffe, R. & Davidson, M. (2010). CNS infection in childhood does not confer risk for later schizophrenia: A case-control study. Schizophrenia Research, 124(1-3): 231-5.

Roe, D., Werbeloff, N. & Gelkopf, M. (2010). Do people with SMI who consume the psychiatric rehabilitation basket of services in Israel have better outcomes than those who do not? Israel Journal of Psychiatry and Related Sciences, 47(3): 166-70. 

Rabany, L., Weiser, M., Werbeloff, N. & Levkovitz, Y. (2011). Assessment of negative symptoms and depression in schizophrenia: Revision of the SANS and how it relates to the PANSS and CDSS. Schizophrenia Research, 126(1-3): 226-230.

Werbeloff, N., Levine S.Z. & Rabinowitz, J. (2012). Elaboration on the association between immigration and schizophrenia: A population based national study disaggregating annual trends, country of origin and sex over 15 years. Social Psychiatry and Psychiatric Epidemiology, 47(2), 303-311.

Weiser, M., Werbeloff, N., Dohrenwend, B.P., Levav, I., Yoffe, R. & Davidson, M. (2012). Do psychiatric registries include all persons with schizophrenia in the general population? A population-based longitudinal study. Schizophrenia Research, 135(1-3):187-91.

Werbeloff, N., Drukker, M., Dohrenwend, B.P., Levav, I., Yoffe, R., Van Os, J., Davidson, M. & Weiser, M. (2012). Self-reported Attenuated Psychotic Experiences as Forerunners of Severe Mental Disorders Later in Life. Archives of General Psychiatry, 69(5):467-75.

Weiser, M., Javitt, D.C., Heresco-Levy, U., Werbeloff, N., Abramovich, Y., Konas, S., Teitelbaum, A., Doron, A., Liba, D., Amital, D., Levkovitz, Y., Zimmerman, Y., Gershon, A.A. & Davidson, M. (2012). A Multicenter, Add-On RCT of Low-Dose D-Serine for Negative and Cognitive Symptoms of Schizophrenia. Journal of Clinical Psychiatry, 73(6):e728-34.

Kaymaz, N., Drukker, M., Lieb, R., Wittchen, H.U., Werbeloff, N., Weiser, M., Lataster, T. & Van Os, J. (2012). Do subthreshold psychotic experiences predict clinical outcomes in unselected non-helpseeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychological Medicine, 20:1-15.

Gelkopf, M., Roe, D., Werbeloff, N., Hasson-Ohayon, A., Mueser, K.T., Caspi, A. & Weiser, M. (2013). The Prevalence of full and partial PTSD among People with Severe Mental Illness in Israel. Journal of Nervous and Mental Disease, 201(3):244-50.

Kaufman-Shriqui, V., Werbeloff, N., Faroy, M., Meiri, G., Shahar. D.R., Fraser, D., Novack, Y., Bilenko, N., Vardi, H., Elhadad, N., Pietrzak, R.H., Harpaz-Rotem, I. (2013). Posttraumatic stress symptoms among preschoolers exposed to ongoing missile attacks in the Gaza War. Depression and Anxiety, 30(5):425-31.

Rabinowitz, J., Werbeloff, N., Caers, I., Mandel, F.S., Stauffer, V., Menard, F., Kinon, B.J. & Kapur, S. (2013). Negative symptoms in schizophrenia - the remarkable impact of inclusion definitions in clinical trials and their consequences. Schizophrenia Research, 150(2-3):334-8.

Rabinowitz, J., Werbeloff, N., Caers, I., Mandel, F.S., Jaeger, J., Stauffer, V., Menard, F., Kinon, B.J. & Kapur, S. (2014). Combining efficacy and completion rates with no data imputation: a composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials. European Neuropsychopharmacology, 24(3):357-68.

Rabinowitz, J., Werbeloff, N., Caers, I., Mandel, F., Stauffer, V., Menard, F., Kinon, B.J. & Kapur, S. (2014). Determinants of antipsychotic response in schizophrenia - implications for practice and future clinical trials. Journal of Clinical Psychiatry, 75(4):e308-16.

Fleischman, A., Werbeloff, N., Yoffe, R., Davidson, M. & Weiser, M. (2014). Schizophrenia and violent crime: a population-based study. Psychological Medicine, 44(14):3051-7.

Gigi, K., Werbeloff, N., Goldberg, S., Portuguese. S., Reichenberg, A., Fruchter, E. & Weiser, M. (2014). Borderline intellectual functioning is associated with poor social functioning, increased rates of psychiatric diagnosis and drug use - A cross sectional population based study. European Neuropsychopharmacology, 24(11):1793-7.

Goldberg, S., Werbeloff, N., Fruchter, E., Portuguese, S., Davidson, M. & Weiser, M. (2014). IQ and obesity in adolescence: a population-based, cross-sectional study. Pediatric Obesity, 9(6):419-26.

Werbeloff, N., Dohrenwend, B.P., Levav, I., Yoffe, R., Van Os, J., Davidson, M. & Weiser, M. (2015). The association between negative symptoms, psychotic experiences and later schizophrenia: a population-based longitudinal study. PLOS One, 10(3):e0119852.

Goldberg, S., Werbeloff, N., Shelef, L., Fruchter, E. & Weiser, M. (2015). Risk of suicide among female adolescents with eating disorders: A longitudinal population-based study. Eating and Weight Disorders, 20(3):295-300.

Rabinowitz, J., Werbeloff, N., Mandel, F.S., De Ridder, F., Schacht, A., Menard, F., Caears, I., Stauffer, V. & Kapur, S. (2015). Usefulness of interim analyses in portending study results in antipsychotic and antidepressant trials. European Neuropsychopharmacology, 25, 1999-2007.

Weiser, M., Kapara, O., Werbeloff, N., Reichenberg, A., Yoffe, R., Fruchter, E., Ginat, K., & Davidson, M. (2015). A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ. Schizophrenia Research, 169(1-3):159-64.

Gelkopf, M., Kodesh, A. & Werbeloff, N. (2016). Mental health medication and service utilization before, during and after war: a nested case-control study of exposed and non-exposed general population, 'at risk', and severely mentally ill cohorts. Epidemiology and Psychiatric Sciences, 25(1):80-90.

Weiser, M., Goldberg, S., Werbeloff, N., Reichenberg, A., Shelef, L., Large, M., Davidson, M. & Fruchter, E. (2016). Risk of completed suicide in 89,049 young males assessed by a mental health professional. European Neuropsychopharmacology, 26(2):341-9.

Levi, L., Werbeloff, N., Pugachova, I., Yoffe, R., Large, M., Davidson, M. & Weiser, M. (2016). Has deinstitutionalization affected inpatient suicide? Psychiatric inpatient suicide rates between 1990 and 2013 in Israel. Schizophrenia Research, 173(1-2):75-8.

Burshtein, S., Dohrenwend, B.P, Levav, I., Werbeloff, N., Davidson, M. & Weiser, M. (2016). Religiosity as a protective factor against suicidal behavior: a historical-prospective cohort study. Acta Psychiatrica Scandinavica, 133(6):481-8.

Gelkopf, M., Lapid, L., Werbeloff, N., Levine, S.Z., Telem, A., Zisman-Ilani, Y. & Roe, D. (2016). A strengths-based case management service for people with serious mental illness in Israel: A randomized controlled trial. Psychiatry Research, 241:182-189.

Werbeloff, N., Dohrenwend, B.P., Levav, I., Haklai, Z., Yoffe, R., Large, M. Davidson, M. & Weiser, M. (2016). Demographic, behavioral and psychiatric risk factors for completed suicide: a 25 year population-based longitudinal cohort study. Crisis: The Journal of Crisis Intervention and Suicide Prevention, 37(2):104-11.

Werbeloff, N., Markou, M., Hayes, J.F., Pitman, A. & Osborn. D.P.J. Individual and Area-Level Risk Factors for Suicidal Ideation and Attempt in people with Severe Depression. (2016). Journal of Affective Disorders, 205:387-392.

Rabinowitz, J., Werbeloff, N., Mandel, F.S., Menard, F., Marangell, M. & Kapur, S. (2016). Initial severity not related to antidepressant benefits or placebo response: a patient level data analysis from 34 randomized controlled trials. British Journal of Psychiatry,209(5):427-428.

Werbeloff, N., Chang, C-K., Broadbent, M., Hayes, J.F., Stewart, R. & Osborn. D.P.J. (2017). Readmission to Acute Mental Health Services Following Contact with Crisis Resolution and Home Treatment Teams: An investigation in two large mental healthcare providers. Lancet Psychiatry, 4(1):49-56.

Weiser, M., Fenchel, D., Werbeloff, N., Goldberg, S., Fruchter, E., Reichenberg, A., Burshtein, S., Large, M., Davidson, M., & Lubin, G. (2017). The association between premorbid cognitive ability and social functioning and suicide among young men: A historical-prospective cohort study. European Neuropsychopharmacology, 27(1):1-7. 

Greene, T., Gelkopf, M., Grinapol, S., Werbeloff, N., Carlson, E. & Lapid, L. (2017). Trajectories of traumatic stress symptoms during conflict: A latent class growth analysis. Journal of Affective Disorders, 220:24-30.

Gelkopf, M., Lapid, L., Grinapol, S., Werbeloff, N., Carlson, E.B. & Greene, T. (2017). Peritraumatic reaction courses during war in individuals with serious mental illness: Gender, mental health status and exposure. Psychiatry: Interpersonal and Biological Processes, 80(4):382–398.

Werbeloff, N., Osborn. D.P.J., Patel, R., Taylor, M., Stewart, R. Broadbent, M., & Hayes, J.F. (2018). The Camden & Islington Research Database: Using Electronic Mental Health Records for Research. PLOS One, 13(1):e0190703.

Lewis, G., Werbeloff, N., Hayes, J.F., Howard, R.J. & Osborn, D.P.J. (2018). Diagnosed depression and socio-demographic factors as predictors of mortality in patients with dementia. British Journal of Psychiatry, 213(2):471-476

Rabinowitz, J., Werbeloff, N., Mandel, F.S., Marangell, M. Menard, F., Schacht, A. & Kapur, S. (2018). Determinants of antidepressant response implications for practice and future clinical trials. Journal of Affective Disorders, 239:79-84.

Aworinde, J., Werbeloff, N., Lewis, G., Livingston, G. & Sommerlad, A. (2018). Dementia Severity at time of Death: a Rigester-Based Cohort study. BMC Psychiatry, 18(1):355.

Fusar-Poli P., Werbeloff, N., Rutigliano, G., Oliver, D., Stahl, D., McGuire, P. & Osborn, D. (2019). Transdiagnositc risk calculator for the automatic detection of individuals at risk and the prediction of psychosis: second replication in an independent national health service trust. Schizophrenia Bulletin, 45(3): 562–570.

Mukadam, N., Lewis, G., Mueller, C., Werbeloff, N., Stewart, R., & Livingston, G. (2019). Ethnic differences in cognition and age in people diagnosed with dementia: a study of electronic health records in two large mental healthcare providers. International Journal of Geriatric Psychiatry, 34(3):504-510.

Currell, E.A., Werbeloff, N., Hayes, J.F. & Bell, V. (2019). Neuropsychiatric analysis of an additional large Capgras delusion cases series. Cognitive Neuropsychiatry, 24(2):123-134.

Velupillai, S., Hadlaczky, G., Baca-Garcia, E., Gorrell, G.M., Werbeloff, N., Nguyen, D., Patel, R., Leightley, D., Downs, J., Hotopf, M. & Dutta, R. Risk assessment tools and data-driven approaches for predicting and preventing suicidal behaviour. Frontiers in Psychiatry,10:36.

non-refereed publications

Lubin, G., Werbeloff, N., Zarka, S. Shmushkevitch, M., Davidson, M. & Weiser, M. (2007). Association between cigarette smoking and post traumatic stress disorder. Romanian Journal of Psychopharmacology, 3-4.

Dove, J., Mistry, A., Werbeloff, N., Osborn, D. & Turjanski, N. (2018). Weekday and seasonal patterns in psychiatric referrals in three major London A&E departments, 2012–2014. BJPsych Bulletin, 42(1):5-9.

PAPERS PRESENTED AT SCIENTIFIC CONFERENCES

Conference talks

Poster presentations